The acquisition focuses on sisunotavir, an RSV fusion inhibitor that UK-based ReViral ... including a follow-up RSV candidate targeting the viral N protein that is in phase 1 testing.

The fusion between Swedish pharmaceutical company ... this time to develop small-molecule protein kinase B (PKB) to further contribute in the fight against cancer. In 2007, AstraZeneca’s ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

It is the highest number of cases recorded since the virus became notifiable. A free RSV vaccine will be made available to pregnant people to protect them and their unborn babies from February 3.

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

It looks like this virus, which leads to symptoms resembling the common cold, has a close connection to respiratory syncytial virus (RSV). After all, both viruses cause respiratory illnesses and have ...

could improve the distribution of cytoplasmic reporter proteins when administered systemically as fusion proteins or cross-linked chimeras. The utility of this motif for noncytoplasmic proteins ...

Future Virology. 2014;9(8):753-767.

This narrowing results from swelling caused by a virus. The respiratory syncytial virus (RSV) causes most bronchiolitis. RSV occurs in epidemics almost every winter. People do not develop life-long ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness myths. On my spare time I enjoy ...

Best whey-protein powders Best collagen-protein powder Best plant-based protein powders All the other protein powders I’ve tried Protein powders can be found in thousands of formulations on tens ...